6.21MMarket Cap0.00P/E (TTM)
0.1200High0.1008Low4.81MVolume0.1050Open0.1100Pre Close528.01KTurnover8.52%Turnover Ratio0.00P/E (Static)57.49MShares70.000052wk High1.86P/B6.09MFloat Cap0.095552wk Low--Dividend TTM56.38MShs Float8534.8500Historical High--Div YieldTTM17.46%Amplitude0.0950Historical Low0.1090Avg Price1Lot Size
CNS Pharmaceuticals Stock Forum
virtual analyst and investor day
CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
CNS Pharmaceuticals (NASDAQ:CNSP)presented updated results from its ongoing pivotal study comparing Berubicin versus Lomustine in adult patients with recurrent glioblastoma (GBM). The study has enrolled 239 patients, with comparable demographics between tr...
No comment yet